Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04740307
Brief Title: Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004)

First Submitted : February 2, 2021
First Submitted that Met QC Criteria : February 2, 2021
First Posted : February 5, 2021

Last Update Submitted that Met QC Criteria : September 14, 2021
Last Update Posted : September 15, 2021 (Estimate)